Regulated activation of receptor tyrosine kinases depends both on the presence of the receptors at the cell surface and on the availability of their ligands. In Drosophila the torso (tor) tyrosine kinase receptor is distributed along the surface of the embryo but it is only activated at the poles by a diffusible extracellular ligand generated at each pole which is trapped by the receptor, thereby impeding further diffusion. However, it is not well understood how this signal is generated, although it is known to depend on the activity of many genes such as torsolike (tsl) and trunk (trk). To further investigate the mechanism involved in the local activation of the tor receptor we have altered the normal expression of the tsl protein by generating females in which the tsl gene is expressed in the oocyte under the control of the tor promoter rather than in the ovarian follicle cells. Analysis of the phenotypes generated by this hybrid gene and its interactions with mutations in other genes in the pathway has enabled us to further dissect the mechanism of tor receptor activation and to define more precisely the role of the different genes acting in this process.
Introduction
Receptor tyrosine kinases are involved in many signalling pathways in cell proliferation and cell differentiation. It is upon ligand binding that these receptors are able to induce their responses; thus, regulated activation of these pathways depends both on the presence of the receptors at the cell surface and on the availability of their ligands. Indeed, the extent of receptor activation can be set up by the limited production or by the restricted diffusion of their ligands (see Jessell and Melton, 1992 for a review). The torso pathway in Drosophila is a particularly appropriate model to address this issue because the torso (tor) receptor is distributed along all the surface of the Drosophila embryo but it is only activated at the poles, where it specifies development of its terminal structures (Schüpbach and Wieschaus, 1986a; Klingler et al., 1988; Casanova and Struhl, 1989; Sprenger et al., 1989) . Activation of the tor receptor has been shown to depend on a diffusible extracellular ligand generated at each pole which is trapped by the receptor, thereby impeding further diffusion (Sprenger and Nüsslein-Volhard, 1992; Casanova and Struhl, 1993) .
The situation for generating the terminal signal is not well understood. Two genes, torso-like (tsl) and trunk (trk), have been identified which are normally required for activation of the tor receptor and have been implicated in the local production or action of the tor ligand (Casanova and Struhl, 1989; Stevens et al., 1990) . tsl expression is restricted to specialised follicle cells at each end of the maturing oocyte (Savant-Bhonsale and Montell, 1993; Martin et al., 1994) and its product appears to be found at both embryonic poles after fertilisation (Martin et al., 1994) . Moreover, its restricted expression in these follicle cells appears to be critical for generation of the localised terminal signal in the embryo because ectopic tsl expression during oogenesis causes central portions of the early embryo to develop terminal structures (Savant-Bhonsale and Montell, 1993; Martin et al., 1994) . By contrast, trk is required in the female germline (Schüpbach and Wieschaus, 1986b) and it codes for a protein with similarities to several types of extracellular growth factors and likely to be secreted and cleaved (Casanova et al., 1995) .
Two other genes, fs(1)pole hole (fs(1)ph) and fs(1)Nasra (fs(1)Nas), seem also to be required for local activation of the tor receptor (Casanova and Struhl, 1989) . These genes are unusual because the majority of mutant alleles at both loci lead to a collapsed egg phenotype, probably due to abnormalities in the vitelline membrane, and only a particular hypomorphic mutation for each gene gives rise to a terminal phenotype (Degelmann et al., 1990) . Thus, it has been proposed that these two genes may have a dual function: they may serve to stabilise the vitelline membrane and they may also be involved in retention or stabilisation of the tsl product in the perivitelline space at the egg pole (Degelmann et al., 1990) . To further investigate the mechanism involved in the local activation of the tor receptor we have altered the normal expression of the tsl protein by generating females in which the tsl gene is expressed in the oocyte under the control of the tor promoter rather than in the ovarian follicle cells. We show that tsl expressed in the germ-line cells is fully functional in the mechanism of tor activation, enabling more precise definition of the spatial and temporal requirements of the tsl product in the generation of the terminal pattern. Moreover, analysis of the interactions between this hybrid gene and mutations in other genes in the terminal system has enabled us to further dissect the mechanism of tor receptor activation. In particular, we discard the possibility that trk could act as an oocyte-to-follicle cell signal instructing tsl expression and we show that fs(1)ph and fs(1)Nas actively link tor receptor activation to a membrane-bound event.
Results

Ubiquitous expression of tsl in the oocyte
To investigate the requirement of tsl function for tor activation we have generated transgenic flies in which the tsl cDNA is under the control of the tor promoter (referred to from now on as the tor-tsl construct; see Section 4). The tor gene is expressed in the germ-line; it is first detected in the nurse cells and once these cells transport their contents into the oocyte the tor mRNA becomes evenly distributed within the oocyte; after egg deposition, the transcript is uniformly distributed in the embryo (Sprenger et al., 1989) . Accordingly, we can detect a uniform low level of tsl expression in early embryos derived from females carrying the tsl gene under the control of the tor promoter (Fig. 1B) .
We have generated 12 lines of transgenic flies that have independently integrated the tor-tsl construct. Five of these lines do not show any particular phenotype but the other seven lines show a variable degree of what has been named the splice phenotype, i.e. deletions of the middle segments of the embryo (Schüpbach and Wieschaus, 1989) . The splice phenotype originated by the expression of this con- struct is very variable and also very sensitive to its copy number (Fig. 2) ; even the weaker lines produce splice phenotypes as the copy number of the tor-tsl constructs increases. This is a phenotype associated with the tor dominant mutations that cause an expansion of the terminal portions of the body at the expense of the embryonic central region (Klingler et al., 1988; Strecker et al., 1989) . Therefore, these phenotypes offer a first indication that general expression of tsl in the oocyte could result in ubiquitous activation of the tor receptor. Furthermore, in the most extreme cases, we can even detect the appearance of ectopic terminal structures, such as filzkörpers (Fig. 2D) . Three of the stronger lines have been chosen for further analysis.
Uniform expression of tsl in the oocyte is able to trigger unrestricted activation of the tor receptor
The phenotypes associated with the tor-tsl construct suggest that uniform expression of tsl in the oocyte is able to trigger activation of the tor receptor all over the embryo. We have performed two additional tests of this hypothesis. First, we have corroborated that in these embryos there is indeed an expansion of the terminal portions of the body at the expense of the middle body segments. Specifically, we have monitored in these embryos the expression pattern of tailless (tll), a gene whose expression is regulated by the tor transduction pathway; while in wild type embryos tll expression is restricted to the embryonic poles (Pignoni et al., 1990) and it expands in mutant embryos where there is spatially-indiscriminate activation of the tor pathway (Steingrímsson et al., 1991) . Indeed, we observed expanded tll expression in embryos derived from females that express tsl ubiquitously in the oocyte (Fig. 1D) . Second, the phenotype generated by tsl expression in the germ-line is suppressed in embryos derived from females lacking the tor gene (Fig. 3 ). In addition, those embryos also display the tor − mutant phenotype, as expected from the upstream role of tsl in tor receptor activation (Casanova and Struhl, 1989) . Hence, we can attribute the phenotype associated with the tor-tsl construct to unrestricted activation of the tor receptor.
Germ-line expression of tsl overcomes the absense of endogenous tsl activity
As mentioned above, a distinct feature of tsl is its somatic expression in some follicle cells flanking the oocyte (Savant-Bhonsale and Montell, 1993; Martin et al., 1994) . In addition, mosaic analysis and transplantation experiments have demonstrated that it is in the somatic follicle cells that tsl function is precisely required (Stevens et al., 1990) . However, the phenotypes associated with the tor-tsl construct indicate that the tsl product has the capacity to function when supplied from the germ-line. To test whether the germ-line expression of tsl can substitute for the endogenous tsl function we have analysed the progeny from tsl mutant females carrying the tor-tsl construct and mutant for different tsl alleles. In particular, we have used the tsl5 allele, an allele of the most severe class of tsl mutants (Savant-Bhonsale and Montell, 1993) .
First, we have analysed their cuticle pattern and found that they show a variable rescue of the tsl phenotype which depends on the copy number of tor-tsl constructs. We observed embryos derived from tsl females carrying one copy of the tor-tsl construct that display a partial rescue of the tsl phenotype without any sign of ectopic activation of the tor receptor. Embryos derived from tsl females carrying two copies of the tor-tsl constructs can even show a complete rescue of the tsl phenotype as judged by the appearance at the posterior cuticle of all the terminal structures (denticle belt of the eighth abdominal segment, filzkörper and posterior spiracles, anal pads and tuft) (Fig. 3B,C) . In addition, some of these embryos also show the abdominal defects associated with inappropriate activation of the tor receptor in the middle body segments (Fig. 3B) .
To further corroborate that germ-line expression of tsl can substitute for the lack of endogenous tsl function we have also analysed the pattern of huckebein (hkb) expression in embryos derived from tsl females carrying the tor-tsl constructs. hkb expression is thought to respond to higher levels of terminal signalling (Furriols et al., 1996) and in wild type embryos it is restricted to the more terminal regions (Brönner and Jäckle, 1991) . While there is no expression of hkb in the posterior pole of embryos derived from tsl females (Fig. 3D) , hkb expression is restored at the posterior pole by the presence of the tor-tsl construct (Fig.  3E ), indicating that even high levels of terminal signalling can be driven by tsl germ-line expression. 
t, tuft). (D) In embryos from tsl
604 females hkb expression is not detected at the posterior pole; expression remains in the anterior domain due to the activity of the anterior system. (E) Rescue of the tsl phenotype can also be observed at the level of hkb expression as its posterior domain is present in embryos derived from tsl 5 females that carry two copies of the tor-tsl construct. (F) Conversely, no rescue of terminal structures or deletions of the middle segments can be observed in embryos from trk 1 females that carry two copies of the tor-tsl construct. The same phenotype as in F is observed in embryos from mutant females for tor XR1 , fs(l)ph 1901 and fs(1)Nas 211 that also carry two copies of the tor-tsl construct.
Triggering of tor activation by tsl expressed in the germ-line requires the product of the trk gene
trk is another gene that is essential for normal activation of the tor receptor (Casanova and Struhl, 1989) . In contrast to tsl, trk is expressed in the germ-line and we have shown that it codes for a protein with similarities to several types of extracellular growth factors and is likely to be the tor ligand (Casanova et al., 1995) . However, it has also been proposed that tsl might itself be the tor ligand (Martin et al., 1994) . According to this view, trk could have a role upstream of the localised expression of tsl, e.g. as an oocyte-to-follicle cell signal involved in specifying the differentiation of specialised follicle cells at each end of the oocyte. Similar induction events have already been documented from the oocyte to specify different fates among follicle cells (Schüpbach, 1987; González-Reyes and St. Johnston, 1994) . To ascertain the role of trk we have investigated whether tsl expression in the germ-line still requires trk function in triggering tor receptor activation. Indeed, we have found that embryos from trk mutant females carrying the tor-tsl construct show neither the splice phenotype nor any rescue of the trk phenotype (Fig. 3) , indicating that trk function is still required for the activation of tor by tsl even when it is expressed in the germ-line under the control of a heterologous promoter. Therefore, trk is required in a process other than for induction of tsl expression. Accordingly, tsl is expressed in the border cells and in a subset of the posterior follicle cells in trk mutant ovaries (Fig. 4) .
Triggering of tor activation by tsl expressed in the germ-line requires the product of the fs(1)ph and fs1)Nas genes
Two other genes of the terminal system, fs(1)ph and fs(1)Nas, are special because the majority of mutant alleles at both loci lead to a collapsed egg phenotype, probably due to abnormalities in the vitelline membrane; only a particular hypomorphic mutation for each gene produces a specific terminal phenotype (Degelmann et al., 1990) . We have shown that they seem to be required for ligand-induced activation of the tor receptor since tor constitutive mutations suppress their terminal phenotypes (Casanova and Struhl, 1989) . Accordingly, it has been proposed that these two genes may have a dual function; they may serve to stabilise the vitelline membrane and they may also be involved in retention or stabilisation of the tsl product in the perivitelline space at the egg pole (Degelmann et al., 1990) . In particular, as it has been proposed that the tsl gene product is secreted from the follicle cells to the vitelline membrane or perivitelline space (Savant-Bhonsale and Montell, 1993; Martin et al., 1994) , the fs(1)ph and fs(1)Nas gene products could be involved in the process of transference of the tsl product from the follicle cells to the germ-line. Thus, their role in the process of tor receptor activation could be dispensable if the tsl product is supplied from the germ-line.
However we have found the opposite, as the tor-tsl construct has no effect in embryos from either fs(l)ph or fs(l)Nas mutant females (Fig. 3) , indicating that the fs(1)ph and the fs(1)Nas functions are still required for tor receptor activation even when tsl is expressed in the germ-line and its product is likely to be secreted from the oocyte rather than from the follicle cells.
Discussion
tsl is the unique gene in the tor pathway that has been found to have restricted expression. Given the uniform distribution of the other known components of the pathway, the restricted expression of tsl in the follicle cells at each end of the oocyte during oogenesis has been singled out as the determinant for local activation of the tor receptor at both poles of the embryo. In agreement with this role, ectopic expression of tsl by means of a heat-shock inducible promoter is able to activate the tor receptor all over the embryo (Savant-Bhonsale and Montell, 1993; Martin et al., 1994) . Previous reports have also been published indicating that tsl RNA injected at the posterior pole in eggs from tsl mutant females could correct the tsl posterior phenotype (Martin et al., 1994) . We have developed a new system of general expression of tsl in the germ-line cells which has allowed us to study more precisely the spatial and temporal requirements for tsl and the relations between tsl and other genes also required for tor receptor activation.
Spatial and temporal requirements of tsl in inducing tor receptor activation
The results reported indicate that the somatic expression of tsl in a subset of follicle cells can serve to ensure that its product is strictly confined to a restricted domain and thus, that the tor receptor is only activated at the embryonic poles. However, expression of tsl in the somatic cells is not critical for its functional role in tor activation since the tsl product supplied from the germ-line is equally functional. The nature of the tsl gene product as a protein likely to be secreted could account for this ability of the tsl protein to be func- tional when expressed either in the somatic or in the germline cells (Martin et al., 1994; and see below) .
The finding that the tor protein is expressed during a restricted period of time just before and during the syncytial blastoderm indicates that activation of the receptor occurs during this period (Casanova and Struhl, 1989) , a conclusion that agrees with the results of cytoplasmic rescue experiments (Klingler et al., 1988) and with the time course of tor phosphorylation (Sprenger et al., 1993) . The time lapse between tsl expression in the follicle cells and tor activation in the oocyte when the follicle cells are no longer present, has prompted the suggestion that a mechanism must exist that ensures that the spatial asymmetry in the somatic cells is transmitted during oogenesis and early embryogenesis until activation of the tor receptor takes place (Casanova and Struhl, 1989) . However it is not clear whether tsl itself is required during embryogenesis at the time of activation of the tor receptor. Our experiments indicate that expression of tsl at the time of tor expression is sufficient to fulfil its role in tor activation and suggest that the tsl product (and not a downstream function of the gene) is functional around the period of time when the tor receptor is present at the blastoderm membrane.
tsl expression and terminal pattern
Two additional remarks can be drawn from the uniform expression of tsl in the germ-line. First, uniform low levels of tsl elicit the tor pathway response just at the embryonic poles; only increasingly high levels of tsl are able to alter pattern in the central regions of the embryo. This observation is in agreement with all the previous reports that have underlined the distinct outcome of the tor pathway when equally activated along all over the embryo (Casanova and Struhl, 1989; Lu et al., 1993; Tsuda et al., 1993; Casanova et al., 1994) . These results have been interpreted as an indication that centrally-located nuclei might respond differently to activity of the tor pathway from nuclei located at the poles, probably due to interactions between terminal and central gap genes (Casanova et al., 1994) . Second, high levels of uniform tsl expression not only disturb central segmentation but are also able to generate ectopic terminal structures, such as filzkörpers, indicating that ectopic tsl expression is able to induce enough levels of tor activity to elicit the morphogenetic responses of the terminal pathway. In a previous report, expression of tsl driven by a heatshock promoter was found not to be able to generate ectopic terminal structures (Savant-Bhonsale and Montell, 1993) . The critical levels achieved by the two systems driving tsl ectopic expression could account for these different results.
trk does not work as an oocyte-to-follicle cell signal instructing tsl expression
Local activation of the tor receptor requires the trk gene, which codes for a protein with similarities to several extracellular growth factors. However, it is the localised expression of tsl in the follicle cells that is responsible for the restricted activation of the tor receptor in the embryo. A similar mechanism operates in the dorsoventral system where spatial information from the follicle cells is responsible for the formation of the embryonic dorsoventral axis (Schüpbach, 1987) . In the dorsoventral system the asymmetry in the follicle cells is induced by a signal from the oocyte: it is the germ-line expression of gurken (grk), a gene coding for a growth factor-like protein, which signals to dorsal follicle cells leading ultimately to the ventral production of an active form of spätzle (spz), the putative ligand of the Toll receptor (Neuman-Silberberg and Schüpbach, 1993; Morisato and Anderson, 1994) . Based on the parallelisms between the two systems, trk could be playing a similar role to grk as a germ-line inducer of restricted tsl expression in the follicle cells. Our results clearly argue against that model, in that tsl expression is normal in trk mutant ovaries and tsl still requires the trk gene product to be effective in the mechanism of tor receptor activation even when expressed out of the follicle cells and under a heterologous promoter. Conversely, these results suggest a more direct role of trk in the activation of the tor receptor and strengthen the suggestion that trk itself could act as a ligand for the tor receptor (Casanova et al., 1995) .
fs(1)ph and fs(1)Nas actively link tor activation to a membrane-bound event
Our results assign an active role to the vitelline membrane in tor activation. Tsl secreted from the oocyte is able to trigger tor activation but still requires fs(1)ph and fs(1)Nas, two genes associated with the integrity of the vitelline membrane. Hence, the products of the fs(1)ph and fs(1)Nas genes are not involved in the mere transference or holding of tsl from the follicle cells. Instead, our results argue for a membrane-bound activity in the mechanism of tor receptor activation. Our results also argue against any polar specificity of the fs(1)ph and fs(1)Nas gene products since they are also required for activation of the tor receptor in the middle region of the embryo by ectopic expression of tsl. Although a direct interaction of tsl with either fs(1)ph or fs(1)Nas could account for these observations, this interaction could occur with another component of the mechanism of tor receptor activation. However, since the tsl product contains leucine-rich repeats implicated in mediating protein-protein and protein-lipid interactions (Savant-Bhonsale and Montell, 1993) , it is tempting to postulate that the tsl product itself could require to be membrane-bound in order to be active. Two additional observations are worth considering. First, it has been proposed that the fs(1)ph and fs(1)Nas products might be assembled into the oocyte plasma membrane or transported into the perivitelline space where they could stabilise the vitelline membrane (Spradling, 1993) . Second, R. Ollo and co-workers (Martin et al., 1994) have made the unique observation that tsl protein is detected at the surface of the syncytial blastoderm in the form of symmetrical caps at both poles. Although it has not been possible to reproduce this last result, both observations make it possible to speculate that localised membrane anchoring of tsl, mediated directly or indirectly by the fs(l)ph or fs(l)N as gene products could be essential for tsl function and hence for the process of tor activation.
Previous characterisation of the trk gene raised the possibility that its product might be secreted intact into the perivitelline fluid layer and locally activated by proteolytic cleavage to generate the ligand for the tor receptor (Casanova et al., 1995) . Our present results are consistent with this prospect. The existence of a membrane-bound event in the mechanism of tor activation fits very well with the putative proteolysis of the trk gene product; the cleavage site in the trk gene product is similar to the one present in the third component of the complement system and cleavage in the complement is an event that occurs in membrane-bound complexes (see Müller-Eberhad, 1988 for a review). Furthermore, the local confinement of this membranebound activity could be the determinant of the spatial restriction of tor activation. Indeed, the tsl product could constitute the link between the membrane-bound event and local restriction in tor activation, perhaps by means of proteolysis of the trk product. Alternatively, it is also possible that tsl itself could directly bind to the tor receptor in the embryonic poles. Unfortunately, the present tools do not make it feasible to ascertain whether the possible binding of tsl at the embryonic poles is dependent on any of the other gene functions of the terminal system. Further experiments will be required to discriminate between these possibilities.
Experimental procedures
Fly strains trk
1 is a mutation that results from a premature stop codon and behaves as a null allele (Casanova et al., 1995) . tor XR1 is a small deficiency that deletes the tor gene (Sprenger et al., 1989) . tsl 5 , tsl 3 , tsl 2 are amino acid substitution mutations ordered according to their decreasing severity (SavantBhonsale and Montell, 1993) , tsl 7 is a spontaneous mutation and tsl 604 is a P element induced mutation (Martin et al., 1994) . fs(1)ph 1901 and fs(1)Nas 211 are mutations in those genes displaying the specific terminal phenotype (Degelmann et al., 1990) .
tor-tsl construct
An XbaI-EcoRI fragment from the tsl cDNA comprising all the coding sequence (Savant-Bhonsale and Montell, 1993) was fused to an EcoRI-XbaI genomic fragment of 3.5 Kb from the tor promoter (Sprenger et al., 1989 ) and the resulting fusion was inserted into the P(ry + ) transformation vector C20.
In situ hybridisation
tsl, tll and hkb probes were generated from cDNA clones provided by D. Montell, J. Lengyel and H. Jäckle, respectively. Whole-mount in situ hybridisations were done following the method of Tautz and Pfeifle (1989) with minor modifications.
